Search

everythinglearnresearchcommunity

for

Search:↓

The 2003 guidelines suggest that while some treatments can regrow hair in alopecia areata, none alter the disease's progression, and wigs may be the best option for extensive hair loss.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

No single treatment is consistently effective for alopecia areata, and more research is needed.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

People with alopecia areata, a skin disease, generally have a poor quality of life, especially if more of their scalp is affected.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

Minoxidil helps hair regrowth in alopecia patients, with 16 having good results and no side effects.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

PRP more effective than minoxidil 5% for treating alopecia areata.

Intralesional triamcinolone acetonide is the most effective treatment for localized alopecia areata.

Nail problems are common in people with alopecia areata, often leading to cosmetic and functional issues, but more research is needed for treatment guidelines.

Combining diphenylcyclopropenone with anthralin is more effective for hair regrowth in alopecia areata than using diphenylcyclopropenone alone, but may cause more side effects.

No systemic treatment for alopecia areata has strong evidence of effectiveness.

People with Major Depressive Disorder have a higher chance of getting Alopecia Areata, and vice versa; antidepressants may lower this risk.

Intralesional triamcinolone acetonide is effective for treating patchy hair loss, and dermoscopy helps detect treatment response and side effects early.

Alopecia areata is linked to thyroid autoimmunity but not type 1 diabetes.

Trichoscopy can effectively tell apart tinea capitis and alopecia areata in children by looking for specific hair shapes.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

People with alopecia areata have similar overall death rates as others but higher risks of death from self-harm, psychiatric issues, and lung cancer in certain cases.

Minoxidil helps hair regrowth in alopecia, but more research needed.

Old treatments for other skin conditions showed promise for hair regrowth in mice with a hair loss condition.

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.

ULBP3 could be a marker for diagnosing alopecia areata incognita and may be linked to its cause and development.

Combining stem cell media with laser or microneedling can effectively regrow hair in alopecia areata.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Apremilast helps regrow hair in hard-to-treat alopecia areata.

Alopecia areata needs new treatments targeting autoimmune processes due to its emotional impact and variable treatment responses.

Fractional laser treatment helped hair regrowth in patients with alopecia areata.

Nonsteroid treatments for alopecia areata show promise but need more high-quality research.